Total bone uptake in management of metastatic carcinoma of the prostate.

[1]  Pitts Wr,et al.  Comparison of quantitative and visual detection of new focal bone lesions. , 1985 .

[2]  O. Israel,et al.  24-Hour/4-hour ratio of technetium-99m methylene diphosphonate uptake in patients with bone metastases and degenerative bone changes. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  K. Mckusick,et al.  A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP). , 1985, International journal of nuclear medicine and biology.

[4]  D. Ihde,et al.  Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma. , 1983, Radiology.

[5]  Pollen Jj.  Bone scanning in prostatic cancer. , 1981 .

[6]  D. Citrin,et al.  The use of serial bone scans in assessing response of bone metastases to systemic treatment , 1981, Cancer.

[7]  D. Citrin,et al.  Systemic treatment of advanced prostatic cancer: development of a new system for defining response. , 1981, The Journal of urology.

[8]  J. Hardy,et al.  An index for monitoring bone metastases from carcinoma of the prostate. , 1980, The British journal of radiology.

[9]  G. Murphy,et al.  An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinoma , 1980, The Prostate.

[10]  W. Greig,et al.  The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M. Potsaid,et al.  Improved method for quantitative bone scanning. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  K. Mckusick,et al.  Pharmacokinetics of technetium-99m diphosphonate. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  H. Pendergrass,et al.  Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. , 1976, Radiology.

[14]  A. C. Buck,et al.  Serial Fluorine-18 bone scans in the follow-up of carcinoma of the prostate. , 1975, British journal of urology.

[15]  E. Gursel,et al.  Comparative evaluation of bone marrow acid phosphatase and bone scanning in staging of prostatic cancer. , 1974, The Journal of urology.

[16]  P. Hudson,et al.  On low acid phosphatase values of patients with known metastatic cancer of the prostate. , 1954, Cancer research.